Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 17;14(10):3517.
doi: 10.3390/jcm14103517.

Correlation Between Idiopathic Immune-Mediated Uveitis and Audiovestibular Involvement: A Cross-Sectional Study

Antonio Bustos-Merlo  1 , Juana Dominguez-Perez  2 , María Del Carmen Olvera-Porcel  3 , Antonio Espejo-González  4 , Juan Manuel Espinosa-Sanchez  2   5   6   7 , Nuria Navarrete-Navarrete  1   8
Affiliations

Correlation Between Idiopathic Immune-Mediated Uveitis and Audiovestibular Involvement: A Cross-Sectional Study

Antonio Bustos-Merlo et al. J Clin Med. .

Abstract

Background/Objectives: Idiopathic immune-mediated uveitis (IIMU) is an intraocular inflammatory condition affecting the uveal tract and adjacent ocular structures, potentially leading to systemic involvement. Audiovestibular symptoms, such as sensorineural hearing loss (SNHL) and balance disturbances, are often underdiagnosed in these patients. The potential correlation between IIMU and audiovestibular dysfunction remains insufficiently studied. This study aimed to estimate the prevalence and describe the clinical characteristics of audiovestibular manifestations in patients with IIMU. Methods: We conducted a cross-sectional observational study of 34 patients with a confirmed diagnosis of IIMU at a tertiary academic center. All participants underwent a standardized neurootological assessment, including pure-tone audiometry, video head impulse testing (vHIT), and cervical vestibular-evoked myogenic potentials (cVEMP). Demographic and clinical data were also collected. Results: Audiovestibular dysfunction was identified in 41.18% of patients, with bilateral SNHL (B-SNHL) being the most common finding. Patients with B-SNHL had a significantly later age of uveitis onset (52.3 ± 14.4 vs. 35.9 ± 13.9 years, p = 0.003) and a higher incidence of ocular complications (83.3% vs. 59.1%, p = 0.252). Furthermore, worsening ophthalmologic activity was observed in 25% of patients with B-SNHL, compared to 0% in those without B-SNHL (p = 0.037). Vestibular dysfunction was also associated with delayed onset of uveitis (51.0 ± 17.4 vs. 36.0 ± 12.2 years, p = 0.006) and a non-significantly higher complication rate (76.9% vs. 61.9%, p = 0.465). Conclusions: Audiovestibular dysfunction is a frequent finding in patients with IIMU and is associated with delayed uveitis onset and greater ocular morbidity. These results support the inclusion of systematic audiovestibular screening in clinical evaluations of IIMU patients and suggest that earlier detection may inform prognosis and guide multidisciplinary management strategies.

Keywords: idiopathic immune-mediated uveitis; intraocular inflammation; multidisciplinary management; sensorineural hearing loss; vestibular disorders; vestibular tests.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Proposed pathophysiologic model of audiovestibular involvement in IIMU.
See this image and copyright information in PMC

References

    1. Gritz D.C., Wong I.G. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491–500. doi: 10.1016/j.ophtha.2003.06.014. - DOI - PubMed
    1. Durrani O.M., Meads C.A., Murray P.I. Uveitis: A potentially blinding disease. Ophthalmologica. 2004;218:223–236. doi: 10.1159/000078612. - DOI - PubMed
    1. Rao N.A. Uveitis in developing countries. Indian J. Ophthalmol. 2013;61:253–254. doi: 10.4103/0301-4738.114090. - DOI - PMC - PubMed
    1. Caspi R.R. A look at autoimmunity and inflammation in the eye. J. Clin. Investig. 2010;120:3073–3083. doi: 10.1172/JCI42440. - DOI - PMC - PubMed
    1. Smith J.R., Thorne J.E., Flaxel C.J., Jain N., Kim S.J., Maguire M.G., Patel S., Weng C.Y., Yeh S., Kim L.A. Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology. Ophthalmology. 2024;131:1107–1120. doi: 10.1016/j.ophtha.2024.02.019. - DOI - PubMed

LinkOut - more resources